← Back to patent-cliff list
CAS 202409-80-1
5-chloro-3-(4-(methylsulfonyl)phenyl)pyridin-2-amine
Codes: ETOR-005
Application context (from source-drug indications)
OsteoarthritisEtoricoxib痛风性关节炎EtoricoxibDysmenorrhoeaEtoricoxibRheumatoid arthritisEtoricoxibAnkylosing spondylitisEtoricoxibParkinson's diseaseEtoricoxib
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Etoricoxib | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
5-chloropyridin-2-amine→3-bromo-5-chloropyridin-2-amine→(4-(methylthio)phenyl)boronic acid→5-chloro-3-(4-(methylthio)phenyl)pyridin-2-amine→5-chloro-3-(4-(methylsulfonyl)phenyl)pyridin-2-amine→2,5-dichloro-3-(4-(methylsulfonyl)phenyl)pyridine→Borate(1-), triethoxy(6-methyl-3-pyridinyl)-, lithium, (T-4)- (9CI)
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.